Overview

Study to Determine The Effect of a Drug Called Neupogen on Stroke Recovery

Status:
Unknown status
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
1. Circulating bone marrow and blood vessel precursors home in to sites of ischemia and aid regeneration of injured tissue 2. Increasing the number of circulating precursors will improve in regeneration of damaged brain following ischemic stroke.
Phase:
Phase 1
Details
Lead Sponsor:
Ottawa Hospital Research Institute
Treatments:
Lenograstim